|
PHF8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.979800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.344950E-01 |
| Normal-vs-Stage2 |
6.942100E-02 |
| Normal-vs-Stage3 |
2.379200E-03 |
| Normal-vs-Stage4 |
4.581800E-02 |
| Stage1-vs-Stage2 |
3.504200E-01 |
| Stage1-vs-Stage3 |
2.140000E-02 |
| Stage1-vs-Stage4 |
3.797000E-01 |
| Stage2-vs-Stage3 |
5.639200E-01 |
| Stage2-vs-Stage4 |
9.324200E-01 |
| Stage3-vs-Stage4 |
4.567000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.593600E-02 |
| Normal-vs-AfricanAmerican |
8.606200E-01 |
| Normal-vs-Asian |
2.414600E-01 |
| Caucasian-vs-AfricanAmerican |
2.746600E-01 |
| Caucasian-vs-Asian |
7.038600E-01 |
| AfricanAmerican-vs-Asian |
4.828000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.032500E-02 |
| Normal-vs-Female |
3.316100E-02 |
| Male-vs-Female |
7.455800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.012800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.632100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.616600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.340200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.459600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.007900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.170000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.250000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.328830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.331800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.210600E-04 |
| Classical-VS-Follicular |
9.628600E-04 |
| Classical-VS-Other |
2.236400E-01 |
| Classical-VS-Normal |
4.276400E-01 |
| Tall-VS-Follicular |
8.350200E-01 |
| Tall-VS-Other |
8.285600E-01 |
| Tall-VS-Normal |
1.239260E-03 |
| Follicular-VS-Other |
9.473000E-01 |
| Follicular-VS-Normal |
1.255670E-03 |
| Other-VS-Normal |
1.149180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.003900E-02 |
| Normal-vs-N1 |
2.404200E-02 |
| N0-vs-N1 |
7.807600E-01 |
|
|
